RxDoctor Payments Data

Khurshid Ghani, MD

Urology · Ann Arbor, MINPI 1740567734

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 56.3% of the total. Reporting peaked in 2022 at $107,097 and has fallen 52.2% since, to $51,172 in 2025. Among urology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$412,927in general payments, 2019–2025

Across 250 payments — averaging $1651.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$233K
  • Lumenis Ltd.$58K
  • Lumenis, Inc$40K
  • Olympus America Inc.$27K
  • KARL Storz Endoscopy-america$26K
  • Coloplast$19K
  • plus $12K from 8 others
$367,047in research payments, 2019–2025

Across 13 payments — averaging $28,234 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coloplast$367K

What the payments were for

  • Consulting fees$170,73141%
  • Speaking & faculty fees$204,95050%
  • Travel & lodging$34,1928%
  • Food & beverage$3,0531%
  • Education$10%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$412,927 in reported general payments places this provider in the 95th percentile of 400 urology providers in Michigan.

See all urology providers in Michigan

Medicare billing

Part B allowed, 2024
$56,344
Medicare patients
143
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Potassium Citrate ErPotassium Citrate16$1,692
Tamsulosin Hcl55$473
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$118
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$29

Paid to pharmacies, not to this prescriber.

Other urology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →